Skip to content

East African Medical Vitals

Request correction

Corporate brand

Unclaimed

East African Medical Vitals is a Ugandan manufacturer of powder-free latex examination and surgical gloves.

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

East African Medical Vitals Limited, commonly known as East African Medical Vitals or EAMV, is a privately held Ugandan medical-supplies manufacturer based at Namanve Industrial Park in Mukono District, east of Kampala. The company produces consumable protective equipment for healthcare use, with its reported core products consisting of powder-free latex examination gloves and powder-free sterile surgical gloves. EAMV has been described as the first company in Africa to manufacture powder-free latex medical gloves, although the precise scope of that distinction is not further specified in the available reference material. The business was established by Ugandan entrepreneurs Ben Kavuya and Brian Kavuya. Its factory development was financed with a combination of founder and investor capital and development-bank borrowing. The available reference material reports a project cost of US$14.5 million, including a US$6.3 million loan from the East African Development Bank at an annual interest rate of 8 percent; these figures relate to the company's establishment and factory investment and are not current valuation or revenue figures. Uganda Development Bank was approached for financing but did not approve the application. ASIGMA Capital, a Ugandan private-equity and investment firm, subsequently became an equity partner, while ownership remained associated with the founders' families. EAMV's manufacturing base is located at Plot 1186 Kyaggwe, Block 113, in Namanve Industrial Park, approximately 19 kilometres east of central Kampala. The location places the company within Uganda's principal industrial corridor and near the country's largest healthcare and commercial market. The operation is oriented toward domestic production of medical consumables that might otherwise be sourced from overseas suppliers, giving it a role in Uganda's industrialization and medical-supply resilience. As reported in December 2021, the factory had annual capacity of approximately 95 million gloves. Its gloves were available in hand-specific and ambidextrous configurations, serving different clinical and procurement requirements. By March 2022, EAMV reportedly employed about 200 people. The company expected employment to exceed 1,000 by 2025 as it expanded its product range and added production shifts; this was a stated expansion expectation rather than a confirmed later employment figure. The company has also prepared for possible production of male condoms, indicating an intended move beyond gloves into additional barrier medical and public-health products. No evidence in the supplied material confirms the commercial launch date or scale of that line. Governance is led by executive chairman Ben Kavuya and managing director Brian Kavuya. Publicly available information on current financial performance, export volumes, product certifications, retail branding, and operations outside Uganda is limited. EAMV should therefore be understood primarily as a Ugandan industrial medical-supplies company with regional ambitions, rather than as a broadly documented multinational consumer brand.

History

East African Medical Vitals was established in Uganda by Ben Kavuya and Brian Kavuya, members of related Ugandan entrepreneurial families. The company was created to manufacture medical consumables locally, with a primary focus on powder-free latex gloves. Its factory was developed at Namanve Industrial Park in Mukono District, an industrial area east of Kampala that provides access to Uganda's principal commercial and healthcare market. The reported investment in the company's establishment was US$14.5 million. A significant portion, US$6.3 million, was borrowed from the East African Development Bank at an interest rate of 8 percent per year. Uganda Development Bank was also approached but declined the financing application. These details describe the reported factory-development financing and should not be interpreted as current corporate financial data. ASIGMA Capital, a Ugandan private-equity and investment firm, became an equity partner, while the company continued to be privately owned by members of the founders' families. EAMV's principal manufacturing activity is the production of powder-free latex examination gloves and powder-free sterile surgical gloves. The company has been reported as the first in Africa to manufacture powder-free latex medical gloves, a distinction presented in the available reference material without a detailed comparative definition. Its products include both hand-specific and ambidextrous glove formats. By December 2021, reported annual production was approximately 95 million gloves, indicating a substantial industrial operation rather than a small-scale medical workshop. The company was also preparing to manufacture male condoms, suggesting a planned extension into other barrier-protection products. The available sources do not establish whether that proposed product line entered full commercial production. In March 2022, EAMV was reported to employ approximately 200 people, with management expecting employment to rise above 1,000 by 2025 through product-line expansion and additional shifts. No later workforce figure is supplied. Corporate governance has been associated with the founding family: Ben Kavuya serves as executive chairman and Brian Kavuya as managing director. Information about later leadership changes, export markets, regulatory certifications, revenues, profitability, and subsequent production expansion is not established by the supplied sources. EAMV's documented history therefore centers on the creation of a Ugandan glove-manufacturing facility, its development financing, its reported production scale, and its proposed diversification into condoms.

  • 2022

    Workforce and expansion plans reported

    [1]

    In March 2022, the company was reported to employ about 200 people and to anticipate substantial recruitment as it expanded products and production shifts.

  • 2021

    Reported annual output reaches 95 million gloves

    [1]

    As reported in December 2021, EAMV had annual production of approximately 95 million gloves across its examination and surgical categories.

  • Company established in Uganda

    [1]

    Ben Kavuya and Brian Kavuya established East African Medical Vitals as a Ugandan manufacturer of medical consumables.

  • Namanve factory developed

    [1]

    The company established its headquarters and main manufacturing facility at Namanve Industrial Park in Mukono District, east of Kampala.

Products and positioning

A Ugandan manufacturer focused on locally produced, powder-free latex medical gloves and the development of domestic medical-consumables capacity.

  • Medical gloves

    Powder-free latex examination gloves

    Disposable latex gloves intended for routine examination and general clinical handling. The powder-free design is positioned for healthcare settings where residual glove powder may be undesirable. The available material identifies this as one of EAMV's principal manufactured products but does not provide detailed sizes, packaging, certifications, or specific customer channels.

  • Medical gloves

    Powder-free sterile surgical gloves

    Sterile latex surgical gloves designed for surgical and other controlled clinical procedures. EAMV produces hand-specific and ambidextrous glove formats across its product offering. Available references do not specify the product's full technical specifications, regulatory approvals, or distribution footprint.

  • Barrier healthcare products

    Male condoms

    A planned product line intended to extend EAMV's manufacturing scope from medical gloves into another latex-based barrier product. The available source describes the company as preparing for condom manufacturing but does not confirm a commercial launch or provide product specifications.

Brand decisions

  • 2022

    Expand products and production shiftsStrategy

    Background

    By March 2022, EAMV was reported to employ approximately 200 people and was preparing to broaden its manufacturing activity.

    Action taken

    Management planned to expand the product line, increase production shifts, and prepare for male-condom manufacturing.

    Aftermath

    The company expected employment to exceed 1,000 by 2025, but the supplied sources do not confirm whether that target was reached.

  • Build domestic medical-glove manufacturing capacityStrategy

    Background

    The founders established EAMV to manufacture consumable medical supplies in Uganda, with powder-free latex gloves as the core product category.

    Action taken

    The company developed a dedicated factory at Namanve Industrial Park and organized production around examination and sterile surgical gloves.

    Aftermath

    The factory became a significant reported Ugandan source of medical gloves, with annual output reported at approximately 95 million gloves in 2021.

    Reported establishment and factory investment. US$14.5 million reported project cost, including a US$6.3 million East African Development Bank loan (Company establishment; figures reported in the cited reference)

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/east-african-medical-vitals · Editorial policy · How profiles are compiled